T1	Participants 182 238	patients undergoing coronary artery bypass graft surgery
T2	Participants 424 508	patients undergoing isolated coronary artery bypass graft surgery from 2000 to 2008.
T3	Participants 648 731	12,855 patients, of whom 7,967 (62.0%) were treated preoperatively with Î²-blockers.
